226 related articles for article (PubMed ID: 27633889)
61. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines.
Yano A; Miwa Y; Kanazawa Y; Ito K; Makino M; Imai S; Hanada N; Nisizawa T
Vaccine; 2013 Mar; 31(11):1510-5. PubMed ID: 23318151
[TBL] [Abstract][Full Text] [Related]
62. Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach.
Paranthaman P; Veerappapillai S
Med Oncol; 2023 Feb; 40(3):105. PubMed ID: 36823384
[TBL] [Abstract][Full Text] [Related]
63. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases.
Shey RA; Ghogomu SM; Esoh KK; Nebangwa ND; Shintouo CM; Nongley NF; Asa BF; Ngale FN; Vanhamme L; Souopgui J
Sci Rep; 2019 Mar; 9(1):4409. PubMed ID: 30867498
[TBL] [Abstract][Full Text] [Related]
64. Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.
Kaumaya PT; Foy KC; Garrett J; Rawale SV; Vicari D; Thurmond JM; Lamb T; Mani A; Kane Y; Balint CR; Chalupa D; Otterson GA; Shapiro CL; Fowler JM; Grever MR; Bekaii-Saab TS; Carson WE
J Clin Oncol; 2009 Nov; 27(31):5270-7. PubMed ID: 19752336
[TBL] [Abstract][Full Text] [Related]
65. A multi-subunit based, thermodynamically stable model vaccine using combined immunoinformatics and protein structure based approach.
Rana A; Akhter Y
Immunobiology; 2016 Apr; 221(4):544-57. PubMed ID: 26707618
[TBL] [Abstract][Full Text] [Related]
66. Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines.
Singh H; Gupta S; Gautam A; Raghava GP
Methods Mol Biol; 2015; 1348():327-40. PubMed ID: 26424284
[TBL] [Abstract][Full Text] [Related]
67. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
[TBL] [Abstract][Full Text] [Related]
68. Peptide vaccines and peptide libraries.
Wiesmüller KH; Fleckenstein B; Jung G
Biol Chem; 2001 Apr; 382(4):571-9. PubMed ID: 11405221
[TBL] [Abstract][Full Text] [Related]
69. Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus).
Azim KF; Hasan M; Hossain MN; Somana SR; Hoque SF; Bappy MNI; Chowdhury AT; Lasker T
Infect Genet Evol; 2019 Oct; 74():103936. PubMed ID: 31233780
[TBL] [Abstract][Full Text] [Related]
70. Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis.
Validi M; Karkhah A; Prajapati VK; Nouri HR
Mol Immunol; 2018 Dec; 104():128-138. PubMed ID: 30448609
[TBL] [Abstract][Full Text] [Related]
71. Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection.
Soares MM; Mehta V; Finn OJ
J Immunol; 2001 Jun; 166(11):6555-63. PubMed ID: 11359807
[TBL] [Abstract][Full Text] [Related]
72. Engineering a novel immunogenic chimera protein utilizing bacterial infections associated with atherosclerosis to induce a deviation in adaptive immune responses via Immunoinformatics approaches.
Saleki K; Alijanizade P; Moradi S; Rahmani A; Banazadeh M; Mohamadi MH; Shahabi F; Nouri HR
Infect Genet Evol; 2022 Aug; 102():105290. PubMed ID: 35568333
[TBL] [Abstract][Full Text] [Related]
73. Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
Samman N; Mohabatkar H; Behbahani M; Ganjlikhani Hakemi M
PLoS One; 2024; 19(6):e0306117. PubMed ID: 38923980
[TBL] [Abstract][Full Text] [Related]
74. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach.
Mehla K; Ramana J
Mol Biosyst; 2016 Mar; 12(3):890-901. PubMed ID: 26766131
[TBL] [Abstract][Full Text] [Related]
75. Design and production of a multiepitope construct derived from hepatitis E virus capsid protein.
Taherkhani R; Farshadpour F; Makvandi M
J Med Virol; 2015 Jul; 87(7):1225-34. PubMed ID: 25784455
[TBL] [Abstract][Full Text] [Related]
76. Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach.
Chauhan V; Rungta T; Goyal K; Singh MP
Sci Rep; 2019 Feb; 9(1):2517. PubMed ID: 30792446
[TBL] [Abstract][Full Text] [Related]
77. Peptide vaccines in breast cancer: The immunological basis for clinical response.
Peres Lde P; da Luz FA; Pultz Bdos A; Brígido PC; de Araújo RA; Goulart LR; Silva MJ
Biotechnol Adv; 2015 Dec; 33(8):1868-77. PubMed ID: 26523780
[TBL] [Abstract][Full Text] [Related]
78. Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.
Kobayashi H; Nagato T; Oikawa K; Sato K; Kimura S; Aoki N; Omiya R; Tateno M; Celis E
Clin Cancer Res; 2005 May; 11(10):3869-78. PubMed ID: 15897588
[TBL] [Abstract][Full Text] [Related]
79. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
Melief CJ; Van Der Burg SH; Toes RE; Ossendorp F; Offringa R
Immunol Rev; 2002 Oct; 188():177-82. PubMed ID: 12445291
[TBL] [Abstract][Full Text] [Related]
80. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
